CRIMEAN-CONGO HEMORRHAGIC FEVER IN EURASIA IN XXI CENTURY: PATHOGENESIS AND TREATMENT
- Authors: PLATONOV A.E1, MALEEV V.V1, SANNIKOVA I.V2, PASECHNIKOV V.D2, KARAN L.S1, PLATONOVA O.V1, KULICHENKO A.N3
-
Affiliations:
- Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
- State Medical Academy, Stavropol, Ministry of Health of Russia
- Anti-Plague Institute, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
- Issue: No 6 (2012)
- Pages: 46-58
- Section: Articles
- URL: https://journals.eco-vector.com/2226-6976/article/view/276305
- ID: 276305
Cite item
Abstract
Full Text
About the authors
A. E PLATONOV
Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
Email: platonov@pcr.ru
Moscow
V. V MALEEV
Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
Email: maleyev@pcr.ru
Moscow
I. V SANNIKOVA
State Medical Academy, Stavropol, Ministry of Health of Russia
V. D PASECHNIKOV
State Medical Academy, Stavropol, Ministry of Health of Russia
Email: passetchnikov@mail.ru
L. S KARAN
Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
Email: aran@pcr.ru
Moscow
O. V PLATONOVA
Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
Email: oplatonov@pcr.ru
Moscow
A. N KULICHENKO
Anti-Plague Institute, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare
Email: kulichenko_an@list.ru
Stavropol
References
- Куличенко А.Н., Малецкая О.В., Василенко Н.Ф., Бейер А.П., Санникова И.В., Пасечников В.Д. и др. Крымская геморрагическая лихорадка в Евразии в XXI веке: эпидемиологические аспекты. Эпидемиол. и инфекц. болезни. Актуал. вопр. 2012; (3): 42—53.
- Платонов А.Е., Малеев В.В., Карань Л.С., Санникова И.В., Пасечников В.Д., Платонова О.В. и др. Крымская геморрагическая лихорадка в Евразии в XXI веке: клиника и диагностика. Эпидемиол. и инфекц. болезни. Актуал. вопр. 2012; (5): 45-54.
- Xiao X., Feng Y., Zhu Z., Dimitrov D.S. Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor. Biochem. Biophys. Res. Commun. 2011; 411(2): 253— 258.
- Walter C.T., Barr J.N. Recent advances in the molecular and cellular biology of bunyaviruses. J. Gen. Virol. 2011; 92(11): 2467—2484.
- Simon M., Johansson C., Mirazimi A. Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J. Gen. Virol. 2009; 90(1): 210—215.
- Simon M., Johansson C., Lundkvist A., Mirazimi A. Microtubule-dependent and microtubule-independent steps in Crimean-Congo hemorrhagic fever virus replication cycle. Virology 2009; 385(2): 313—322.
- Rodrigues R., Paranhos-Baccala G., Vernet G., Peyrefitte C.N. Crimean-Congo hemorrhagic fever virus-infected hepatocytes induce ER-stress and apoptosis crosstalk. PLoS One 2012; 7(1): e29712.
- Connolly-Andersen A.M., Douagi I., Kraus A.A., Mirazimi A. Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 2009; 390(2): 157—162.
- Connolly-Andersen A.M., Moll G., Andersson C. et al. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J. Virol. 2011; 85(15): 7766—7774.
- Feldmann H., Geisbert T.W. Ebola haemorrhagic fever. Lancet 2011; 377(9768): 849—862.
- Ozturk B., Kuscu F., Tutuncu E. et al. Evaluation of the association of serum levels of hyaluronic acid, sICAM-1, sVCAM-1, and VEGF-A with mortality and prognosis in patients with Crimean-Congo hemorrhagic fever. J. Clin. Virol. 2010; 47(2): 115—119.
- Bodur H., Akinci E., Onguru P. et al. Evidence of vascular endothelial damage in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 2010; 14(8): e704—e707.
- Yilmaz G., Mentese A., Kaya S. et al. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 2011; 50(3): 209—211.
- Karlberg H., Tan Y.J., Mirazimi A. Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J. Biol. Chem. 2011; 286(5): 3227— 3234.
- Bertolotti-Ciarlet A., Smith J., Strecker K. et al. Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J. Virol. 2005; 79(10): 6152—6161.
- Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008; 8(7): 559—568.
- Versteeg G.A., Garcia-Sastre A. Viral tricks to grid-lock the type I interferon system. Curr. Opin. Microbiol. 2010; 13(4): 508—516.
- Weber F., Mirazimi A. Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 2008; 19(5β6): 395—404.
- Karlberg H., Lindegren G., Mirazimi A. Comparison of antiviral activity of recombinant and natural interferons against Crimean-Congo hemorrhagic fever virus. Open Virol. J. 2010; 4: 38—41.
- Andersson I., Karlberg H., Mousavi-Jazi M. et al. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J. Med. Virol. 2008; 80(8): 1397—1404.
- Соколова Т.М. Регуляция генов системы интерферона при вирусных инфекциях (альфа-, флави- и найровирусы). В кн.: Арбовирусы и арбовирусные инфекции. Под ред. А.М. Бутенко. Тула: ЗАО «Гриф и К», 2007; 46—51.
- Bereczky S., Lindegren G., Karlberg H. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J. Gen. Virol. 2010; 91(6): 1473—1477.
- Bente D.A., Alimonti J.B., Shieh W.J. et al. Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J. Virol. 2010; 84(21): 11089—11100.
- Butenko A.M., Chumakov M.P. Isolation of Crimean-congo hemorrhagic fever virus from patients and from autopsy specimens. Arch. Virol. 1999; Suppl 1: 295—301.
- Смирнова С.Е. Крымская-Конго геморрагическая лихорадка (этиология, эпидемиология, лабораторная диагностика). М.: АТиСО, 2007. 304 с.
- Karan’ L.S., Platonov A.E., Sannikova I.V. et al. Viral load at Crimean-Congo hemorrhagic fever and its clinical significance. Abstracts Book of International Conference on Emerging Infectious Diseases. Atlanta: 2004; 125.
- Карань Л.С., Платонов А.Е., Смирнова С.Е., Вышемирский О.И., Журавлев В.И., Еременко Е.И. и др. Генетические исследования при КГЛ: от диагностики до молекулярной эпидемиологии. В кн.: Арбовирусы и арбовирусные инфекции. Под ред. А.М. Бутенко. Тула: ЗАО «Гриф и К», 2007; 57—61.
- Гаранина С.Б., Шипулин Г.А., Журавлев В.И., Платонов А.Е. Определение вирусной нагрузки у больных геморрагической лихорадкой с почечным синдромом (ГЛПС) с использованием ПЦР в режиме реального времени. Журн. микробиол. 2007; (3): 66—69.
- Cevik M.A., Erbay A., Bodur H. et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin. Infect. Dis. 2007; 45 (7): e96-e100.
- Wolfel R., Paweska J.T., Petersen N. et al. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg. Infect. Dis. 2007; 13(7): 1097—1100.
- Saksida A., Duh D., Wraber B. et al. Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever. Clin. Vaccine Immunol. 2010; 17(7): 1086—1093.
- Ergonul O., Tuncbilek S., Baykam N. et al. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 2006; 193(7): 941—944.
- Санникова И.В., Пасечников В.Д., Малеев В.В. Циркулирующие цитокины как маркеры синдрома системного воспалительного ответа при Крымской-Конго геморрагической лихорадке. Эпидемиол. и инфекц. бол. 2007; (5): 31—35.
- McFadden G., Mohamed M.R., Rahman M.M., Bartee E. Cytokine determinants of viral tropism. Nat. Rev. Immunol. 2009; 9(9): 645—655.
- Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004; 64(3): 145—160.
- Малеев В.В., Галимзянов Х.М., Бутенко А.М., Черенов И.В. Крымская геморрагическая лихорадка. М. — Астрахань: Изд-во АГМА, 2003. 120 с.
- Санникова И.В. Крымская-Конго геморрагическая лихорадка: клинико-патогенетические аспекты и оптимизация лечения. Автореф. дис.. д-ра мед. наук. М., 2009.
- Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol. 1979; 15(4): 307—417.
- Keshtkar-Jahromi M., Kuhn J.H., Christova I. et al. Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies. Antiviral Res. 2011; 90(2): 85—92.
- Brandtzaeg P., van Deuren M. Classification and pathogenesis of meningococcal infections. Methods Mol. Biol. 2012; 799: 21—35.
- Белов А.В., Ларичев В.Ф., Галкина И.А., Хуторецкая Н.В., Бутенко А.М., Константинова И.Д. и др. Активность отечественного рибавирина в опытах in vitro на моделях вирусов крымской геморрагической лихорадки, лихорадки долины Рифт, Тягиня и Дхори. Вопр. вирусол. 2007; 52(1): 34—35.
- Mardani M., Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch. Iran Med. 2007; 10(2): 204—214.
- Cevik M.A., Elaldi N., Akinci E. et al. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever. J. Infect. 2008; 57(4): 350—351.
- Muller M.P., Dresser L., Raboud J. et al. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy 2007; 27(4): 494—503.
- Ascioglu S., Leblebicioglu H., Vahaboglu H., Chan K.A. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis. J. Antimicrob. Chemother. 2011; 66(6): 1215—1222.
- Yilmaz G.R., Buzgan T., Irmak H. et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 20022007. Int. J. Infect. Dis. 2009; 13(3): 380—386.
- Soares-Weiser K., Thomas S., Thomson G., Garner P. Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis. BMC Infect. Dis. 2010; 10: 207.
- Alavi-Naini R., Moghtaderi A., Koohpayeh H.R. et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. J. Infect. 2006; 52(5): 378—382.
- Mardani M., Jahromi M.K., Naieni K.H., Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Iran. Clin. Infect. Dis. 2003; 36(12): 1613—1618.
- Sharifi-Mood B., Metanat M., Ghorbani-Vaghei A. et al. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch. Iran Med. 2009; 12(2): 151—153.
- Izadi S., Salehi M. Evaluation of the efficacy of ribavirin therapy on survival of Crimean-Congo hemorrhagic fever patients: a case-control study. Jpn. J. Infect. Dis. 2009; 62(1): 11—15.
- Tasdelen Fisgin N., Ergonul O., Doganci L., Tulek N. The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising. Eur. J. Clin. Microbiol. Infect. Dis. 2009; 28(8): 929—933.
- Guyatt G.H., Oxman A.D., Vist G.E. et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336(7650): 924—926.
- Bodur H., Erbay A., Akinci E. et al. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 2011; 15(1): e44—e47.
- Koksal I., Yilmaz G., Aksoy F. et al. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey. J. Clin. Virol. 2010; 47(1): 65—68.
- Arda B., Aciduman A., Johnston J.C. A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations. J. Med. Ethics 2012; 38(2): 117—120.
- Малеев В.В., Черенов И.В., Галимзянов Х.М., Аршба Т.Е., Красков А.В. К вопросу об этиотропной терапии крымской геморрагической лихорадки. Инфекц. бол. 2005; 3(2): 76—79.
- Санникова И.В., Пасечников А.Д., Малеев В.В., Первушин Ю.В. Крымская-Конго геморрагическая лихорадка в Ставропольском крае: особенности течения тяжелых форм и предикторы летальности. Инфекц. бол. 2007; 5(4): 25—28.
- Flusin O., Vigne S., Peyrefitte C.N. et al. Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin. Virol. J. 2011; 8: 249.
- Rider T.H., Zook C.E., Boettcher T.L. et al. Broad-spectrum antiviral therapeutics. PLoS One 2011; 6(7): e22572.